Reproductive Genetics and Today's Patient Options: Prenatal Diagnosis

Mount Sinai Journal of Medicine

Volumn 65, Issue 3, 1998, Pages 173-177

  Willner, Judith P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

fetoprotein screening; Amniocentesis; Chorionic villus sampling; Fetal blood sampling; Fetal diagnosis; Genetic counseling; Genetic screening techniques; Genetic testing; Prenatal diagnosis

Indexed keywords

ALPHA FETOPROTEIN;

AMNIOCENTESIS; AMNION FLUID; ARTICLE; BIOPSY; CHEMISTRY; CHORION VILLUS SAMPLING; ECHOGRAPHY; FEMALE; FETUS; FETUS BLOOD; GENETIC COUNSELING; GENETIC DISORDER; GENETIC PROCEDURES; GENETICS AND REPRODUCTION; HIGH RISK PREGNANCY; HUMAN; METHODOLOGY; PATHOLOGY; PREGNANCY; PRENATAL DIAGNOSIS;

GENETICS AND REPRODUCTION;

ALPHA-FETOPROTEINS; AMNIOCENTESIS; AMNIOTIC FLUID; BIOPSY; CHORIONIC VILLI SAMPLING; FEMALE; FETAL BLOOD; FETUS; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC TECHNIQUES; HUMANS; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 0032060373     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Serr DM, Sachs L, Danon M. Diagnosis of sex before birth using cells from amniotic fluid. Bull Res Council Israel 1955; 5B:129-138.
2. Steele MW, Breg WR. Chromosome analysis of human amniotic-fluid cell. Lancet 1966; 1383-1385.
3. Jacobson CB, Barter RH. Intrauterine diagnosis and management of genetic defects. Am J Obstet Gynecol 1967; 99:796-807.
4. Galjaard H. European experience with the prenatal diagnosis of congenital disease: a survey of 6121 cases. Cytogenet Cell Genet 1976; 16:453-467.
5. Golbus MS. The antenatal detection of genetic disorders; current status and future prospects. Obstet Gynecol 1976; 48:497-506.
6. Golbus MS, Loughman WD, Epstein CJ, et al. Prenatal cytogenetic diagnosis in 3000 amniocenteses. N Engl J Med 1979; 300:157-163.
7. Hsu LYF, Kaffe S, Yahr F, et al. Prenatal cytogenic diagnosis: First 1000 successful cases. Am J Med Genet 1978; 2:365-383.
8. NICHD National Registry for Amniocentesis Study Group: Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy. JAMA 1976; 236:1476.
9. Milunsky A, Atkins L. Prenatal diagnosis of genetic disorders and analysis of experience with 600 cases. JAMA 1974; 230:232-235.
10. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989; 320:609-617.
11. Ledbetter DH, Martin AO, Verlinsky Y, et al. Cytogenetic results of chorionic villus sampling: high success rate and diagnostic accuracy in the United States collaborative study. Am J Obstet Gynecol 1990; 162:495-501.
12. Jackson LG, Zachary JM, Fowler SE, et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. N Engl J Med 1992; 327:594-598.
13. Weaver D. Catalog of prenatally diagnosed conditions. 2nd ed. Baltimore: Johns Hopkins University Press; 1992.
14. Milunsky A, editor. Genetic disorders and the fetus: diagnosis, prevention, and treatment. 3rd ed. Baltimore: Johns Hopkins University Press; 1992.
15. Hook EB. Differences between rates of trisomy 21 (Down syndrome) and chromosomal abnormalities diagnosed in live births and in cells cultured after second-trimester amniocentesis: suggested explanations and implications for genetic counseling and program planning. Birth Defects 1978; 14:249-267.
16. Firth HV, Body PA, Chamberlain P, et al. Severe limb abnormalities after chorionic villus sampling at 56-66 days gestation. Lancet 1991; 337:127.
17. Burton BK, Schulz C, Burd LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol 1992; 79:726.
18. Kuliev AM, Modell B, Jackson L, et al. Chorionic villus sampling (CVS). World Health Organization/European Regional Office (WHO/EURO) meeting statement on the use of CVS in prenatal diagnosis. J Assist Reprod Genet 1992; 9:299.
19. Golbus MS, Dan WY, Naglich-Craig M. Fetal blood sampling in mid trimester pregnancies. Am J Obstet Gynecol 1976; 124:653-655.
20. D'Alton ME, DeCherney AH. Prenatal diagnosis. N Engl J Med 1993; 328:114-119.
21. Bergstrand C, Czar B. Demonstration of a new protein in serum from the human fetus. Scand J Clin Lab Invest 1956; 8:174.
22. Gitlin D, Boesman M. Serum alphafetoprotein albumin and gamma G-globulin in the human conceptus. J Clin Invest 1966; 45:1826-1838.
23. Brock DJH, Sutcliffe RG. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet 1972; 2:197-199.
24. UK collaborative study on alpha-fetoprotein in relation to neural tube defects, anencephaly, and open spina bifida in early pregnancy. Lancet 1979; 2:651-661.
25. Crandall BF, Robinson L, Grau P. Risks associated with an elevated maternal serum alphafetoprotein level. Am J Obstet Gynecol 1991; 65:581-585.
26. Cheng EY, Luthy DA, Zebelman AM, et al. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alphafetoprotein, HCG, and unconjugated estriol. Obstet Gynecol 1993; 81:72-77.